| A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition MP Mak, P Tong, L Diao, RJ Cardnell, DL Gibbons, WN William, ... Clinical Cancer Research 22 (3), 609-620, 2016 | 115 | 2016 |
| Evolução do zumbido e da audição em pacientes com audiometria tonal normal TG Sanchez, MP Mak, MEB Pedalini, CPD Levy, RF Bento Arq Int Otorrinolaringol 9 (3), 220-27, 2005 | 28 | 2005 |
| Percutaneous transhepatic biliary drainage in patients with advanced solid malignancies: prognostic factors and clinical outcomes MC Teixeira, MP Mak, DF Marques, F Capareli, FC Carnevale, ... Journal of gastrointestinal cancer 44 (4), 398-403, 2013 | 24 | 2013 |
| Targeting the epidermal growth factor receptor for head and neck cancer chemoprevention MP Mak, WN William Jr Oral oncology 50 (10), 918-923, 2014 | 23 | 2014 |
| Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition MP Mak, VTC e Silva, RM Martin, AM Lerario, L Yu, PMG Hoff, ... Supportive Care in Cancer 20 (9), 2195-2197, 2012 | 23 | 2012 |
| Cisplatin based chemoradiation late toxicities in head and neck squamous cell carcinoma patients. CGJ Rivelli TG, Mak MP, Martins RE, da Costa E Silva VT Discovery Medicine 20 (108), 57-66, 2015 | 22 | 2015 |
| Is there still a role for induction chemotherapy in locally advanced head and neck cancer? MP Mak, BS Glisson Current opinion in oncology 26 (3), 247-251, 2014 | 19 | 2014 |
| Modified FLOX as first-line chemotherapy for metastatic colorectal cancer patients in the public health system in Brazil: Effectiveness and cost-utility analysis DR Nebuloni, MP Mak, FH Souza, DF Saragiotto, T Júlio, G De Castro Jr, ... Molecular and clinical oncology 1 (1), 175-179, 2013 | 14 | 2013 |
| A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer R Ferrarotto, K Machado, MP Mak, N Shah, TK Takahashi, FP Costa, ... European Journal of Cancer 48 (6), 820-826, 2012 | 14 | 2012 |
| Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes REO Ramos, M Perez Mak, MFS Alves, GHM Piotto, TK Takahashi, ... Journal of global oncology 3 (6), 728-733, 2017 | 9 | 2017 |
| Cardiac Safety of (Neo) Adjuvant Trastuzumab in the Community Setting: A Single-Center Experience LG da Fonseca, D de Melo Gagliato, TK Takahashi, MP Mak, ... Breast Care 9 (4), 255, 2014 | 8 | 2014 |
| Postradiation matrix metalloproteinase-20 expression and its impact on dental micromorphology and radiation-related caries W Gomes-Silva, AC Prado-Ribeiro, TB Brandao, K Morais-Faria, ... Caries research 51 (3), 216-224, 2017 | 7 | 2017 |
| Pulmonary nodules in patients with nonpulmonary cancer: not always metastases R Caparica, MP Mak, CH Rocha, PHI Velho, P Viana, MRL Moura, ... Journal of Global Oncology 2 (3), 138-144, 2016 | 6 | 2016 |
| Tinnitus and Hearing Evolution in Normal Hearing Patients Evolução do Zumbido e da Audição em Pacientes com Audiometria Tonal Normal TG Sanchez, MP Mak, MEB Pedalini, CPD Levy, RF Bento | 5* | 2005 |
| Tinnitus and Hearing Evolution in Normal Hearing Patients TG Sanchez, MP Mak, MEB Pedalini, CPD Levy, RF Bento Archives of Otolaryngology 9 (3), 227-330, 2005 | 5 | 2005 |
| Tinnitus and Hearing Evolution in Normal Hearing Patients TG Sanchez, MP Mak, MEB Pedalini, CPD Levy, RF Bento Archives of Otolaryngology 9 (3), 227-330, 2005 | 5 | 2005 |
| Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1 R Caires-Lima, K Cayres, B Protásio, I Caires, J Andrade, L Rocha, ... Ecancermedicalscience 12, 831, 2018 | 4 | 2018 |
| Multiagent chemotherapy for metastatic adenocarcinoma of the seminal vesicle RSC Guindalini, MP Mak, TK Takahashi, L Testa, C Dzik Anti-cancer drugs 25 (1), 115-119, 2014 | 4 | 2014 |
| Referral of lung cancer patients to specialized clinical oncology care: Instituto do Câncer do Estado de São Paulo 2010-2011 R Caires-Lima, TK Takahashi, MP Mak, FSR Roitberg, CHA Teixeira, ... Journal of Thoracic Oncology, 2012 | 4 | 2012 |
| Activity and safety of sunitinib in poor risk metastatic renal cell carcinoma patients R Barroso-Sousa, RR Munhoz, MP Mak, LG Fonseca, A Fede, RDM Linck, ... International braz j urol 40 (6), 835-841, 2014 | 3 | 2014 |
Gilberto de Castro JuniorMédico Assistente Doutor, Serviço de Oncologia Clínica, Instituto do Câncer do Estado de São PauloVerified email at lim24.fm.usp.br
